847442317 | PUO | 82161933 | | 4851171 | 7/14/2005 12:00:00 AM | Atrial fibrilation | | DIS | Admission Date: 4/4/2005 Report Status: Discharge Date: 10/3/2005 ****** DISCHARGE ORDERS ****** ABO , RON P. 721-75-63-2 Gacoll Oaks Service: CAR DISCHARGE PATIENT ON: 11/29/05 AT 11:00 AM CONTINGENT UPON HO evaluation WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES Attending: PETTINGER , DOUGLASS N. , M.D. CODE STATUS: Full code DISPOSITION: Home w/ services DISCHARGE MEDICATIONS: ACETYLSALICYLIC ACID 325 MG PO QD Override Notice: Override added on 9/13/05 by FANIEL , GAYLENE G. , M.D. , PH.D. on order for COUMADIN PO ( ref # 17032720 ) POTENTIALLY SERIOUS INTERACTION: ASPIRIN &amp; WARFARIN Reason for override: aware ALLOPURINOL 200 MG PO QD Override Notice: Override added on 9/13/05 by FANIEL , GAYLENE G. , M.D. , PH.D. on order for COUMADIN PO ( ref # 17032720 ) SERIOUS INTERACTION: ALLOPURINOL &amp; WARFARIN Reason for override: aware KLONOPIN ( CLONAZEPAM ) 1 MG PO BID PRN Insomnia , Anxiety COLCHICINE 0.3 MG PO QD Override Notice: Override added on 9/13/05 by FANIEL , GAYLENE G. , M.D. , PH.D. on order for RAPAMYCIN PO ( ref # 29701624 ) POTENTIALLY SERIOUS INTERACTION: COLCHICINE &amp; SIROLIMUS POTENTIALLY SERIOUS INTERACTION: COLCHICINE &amp; SIROLIMUS Reason for override: aware - on as stable home med. 
DOBUTAMINE HCL IV 2 mcg/kg/min in D5W continuous IV HYDRALAZINE HCL 25 MG PO BID HOLD IF: SBP&lt;80 Food/Drug Interaction Instruction Take consistently with meals or on empty stomach. 
ISORDIL ( ISOSORBIDE DINITRATE ) 40 MG PO BID PREDNISONE 10 MG PO QD ALDACTONE ( SPIRONOLACTONE ) 25 MG PO QD Food/Drug Interaction Instruction Give with meals Alert overridden: Override added on 9/13/05 by COSE , LATASHIA C. , M.D. , M.B.A. SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; SPIRONOLACTONE Reason for override: patient requires COUMADIN ( WARFARIN SODIUM ) 4 MG PO QPM Starting NOW ( 9/10 ) Instructions: WITHIN HOUR OF PHARMACY APPROVAL Food/Drug Interaction Instruction No high Vitamin-K containing foods Alert overridden: Override added on 9/13/05 by FANIEL , GAYLENE G. , M.D. , PH.D. POTENTIALLY SERIOUS INTERACTION: ASPIRIN &amp; WARFARIN SERIOUS INTERACTION: ALLOPURINOL &amp; WARFARIN POTENTIALLY SERIOUS INTERACTION: SIMVASTATIN &amp; WARFARIN Reason for override: aware ZOCOR ( SIMVASTATIN ) 40 MG PO QHS Food/Drug Interaction Instruction Avoid grapefruit unless MD instructs otherwise. 
Override Notice: Override added on 9/13/05 by FANIEL , GAYLENE G. , M.D. , PH.D. on order for COUMADIN PO ( ref # 17032720 ) POTENTIALLY SERIOUS INTERACTION: SIMVASTATIN &amp; WARFARIN Reason for override: aware K-DUR ( KCL SLOW RELEASE ) 20 MEQ PO BID As per PUO Potassium Chloride Policy: each 20 mEq dose to be given with 4 oz of fluid Override Notice: Override added on 9/13/05 by COSE , LATASHIA C. , M.D. , M.B.A. on order for ALDACTONE PO ( ref # 07373572 ) SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; SPIRONOLACTONE Reason for override: patient requires TORSEMIDE 80 MG PO QD Alert overridden: Override added on 9/13/05 by COSE , LATASHIA C. , M.D. , M.B.A. on order for TORSEMIDE PO ( ref # 76543121 ) Pt. has a POSSIBLE allergy to Sulfa; reaction is Rash. 
Reason for override: patient tolerates CELLCEPT ( MYCOPHENOLATE MOFETIL ) 500 MG PO BID Food/Drug Interaction Instruction Give on an empty stomach ( give 1hr before or 2hr after food ) Food decreases peak by up to 40% NIFEREX TABLET 150 MG PO BID Number of Doses Required ( approximate ): 6 RAPAMYCIN ( SIROLIMUS ) 0.5 MG PO QD Alert overridden: Override added on 9/13/05 by FANIEL , GAYLENE G. , M.D. , PH.D. POTENTIALLY SERIOUS INTERACTION: COLCHICINE &amp; SIROLIMUS POTENTIALLY SERIOUS INTERACTION: COLCHICINE &amp; SIROLIMUS Reason for override: aware - on as stable home med. 
NEXIUM ( ESOMEPRAZOLE ) 40 MG PO QD DIET: Fluid restriction: 2 liters DIET: House / Low chol/low sat. 
fat DIET: 2 gram Sodium RETURN TO WORK: Not Applicable FOLLOW UP APPOINTMENT( S ): Please follow up with the PUO Heart Failure Service as scheduled , Arrange INR to be drawn on 4/16/05 with f/u INR's to be drawn every 4-7 days. 
INR's will be followed by PUO Anticoagulation clinic ALLERGY: Sulfa , Penicillins , SUCCINYLCHOLINE CHLORIDE , IV Contrast , Morphine ADMIT DIAGNOSIS: Atrial fibrilation with RVR. 
PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission ) Atrial fibrilation OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay s/p cardiac transplant htn obesity CRI gout ( gout ) s/p ccy ( S/P cholecystectomy ) pulm amiodarone toxicity OPERATIONS AND PROCEDURES: OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. ) anticoagulation , Management of CHF BRIEF RESUME OF HOSPITAL COURSE: HPI: The patient is a 33-year-old female with a history of cardiac transplant and declining ventricular function is admitted from Heart Failure Clinic after presenting for follow up eval and noted to have new atrial fibrillation with VR of 130. 
Mrs. Abo is known to the service and was recently discharged following a CHF admission requiring IV diuresis and pressor support. 
She was discharged on dobutamine 2mcg/kg/min and PO torsamide. 
In the intervening period she has been feeling well. 
She has been quite active. 
She has had no dizziness / lightheadedness. 
No syncope. 
Denies any feeling of palpitations. 
Her weight has been stable. 
ROS: No F/C/NS. 
Change in wt. + LE swelling. 
+ SOB. 
Decreased exercise tolerance. 
Orthopnea PND. 
No cough. 
No URI sx. 
No change in bowel habits. 
No urgency , dysuria or frequency. 
No nocturia. 
No arthralgias or myalgias PMH: 1. Dilated cardiomyopathy status post cardiac transplant 1989. 
2. Episode of rejection of her graft in 1995. 
3. Deterioration of LV function in 2000 4. On annual surveillance , 75% RCA lesion was noted on prior cath and was subsequently stented. 
5. Prior admission complicated by esophagitis believed to be secondary to immediate-release potassium. 
6. Chronic renal insufficiency with baseline creatinine of 1.5. 
7. SVT. 8. Gout. 
9. Amiodarone pulmonary toxicity. 
10. 
Status post cholecystectomy. 
MEDS: ( on D/C ) 1. Aspirin 325 mg p.o. daily. 
2. Allopurinol 200 mg p.o. daily. 
3. Colchicine 0.3 mg daily. 
4. Dobutamine IV drip 2 mcg/kg/min 5. Pepcid 20 mg p.o. daily. 
6. Hydralazine 25 mg twice a day. 
7. Isordil 40 mg twice daily. 
8. Prednisone 10 mg q.a.m. 9. K-Dur 20 mEq twice daily 10. 
Aldactone 25 mg p.o. daily. 
11. 
Zocor 40 mg q.h.s. 12. Torsemide 80 mg p.o. daily. 
13. 
CellCept 500 mg p.o. twice a day. 
14. 
Niferex tablets 150 mg p.o. twice daily. 
15. 
Nexium 40 mg p.o. daily. 
16. 
Tylenol 325-650 mg p.o. q.6h. 
for pain p.r.n. 17. Clonopin 1 mg p.o. b.i.d. p.r.n. anxiety. 
18. Rapamycin 0.5mg daily ALLERGIES: IV contrast - hives ( has tolerated contrast when treated with Benadryl ) , penicillin - rash. 
Sulfa - rash. 
SOCIAL HISTORY: The patient is married and lives at home with her husband and two children , 6 and 4 years of age. 
She denies tobacco use. 
Denies ethanol use. 
EXAM: VS: T97 , P128 , BP120/20 , RR 18 , 98 O2Sat RA Gen: Pt in bed , Alert , NAD HEENT: Anicteric , PERRLA , EOMI , MMM , OP Clear Neck: Supple , No LAD , JVP approx 10cm CV: Tachycardic , regular , Nml s1s2 , Prominent gallop ( difficult to termine s3 vs s4 given rate. 
Pulm: CTA with mild decrease in BS at RLB Abd: Obese , Soft , NT/ND No HSM or mass appreciated. 
+ striea and echymosis. 
Ext: No C/C , No Edema , DP pulses 2+ Bilat Neuro: Grossly Nml. 
LABS: Pending STUDIES: EKG: AFIB with rate 138 , RBB and LAFB. 
1/28/05 , echo showed an EF of 30% bilaterally decreased ventricular function and bilateral atrial enlargement with severe TR and MR , PIT estimated 11. 8/30/05 , exercise tolerance test ( dobutamine ) no EKG changes , baseline hypokinesis , no changes in wall motion abnormality. 
10/10/05 , cardiac catheterization - left main , left circumflex , right coronary artery without significant lesions. 
A 60% mid LAD lesion. 
RA 22 , PCW 25 with V waves - 35. 
IMPRESSION: Mrs Abo is a 33 F s/p cardiac transplant 1989 with allograft CAD and declining ventricular function and on ionotropic support now with new A Fib. Given tenuous function A Fib likely will be poorly tolerated. 
PLAN: 1 )CV a. Isch - Cont. 
ASA , Statin , hydral and nitrate. 
No evidence of active ischemia. 
b. Pump - Cont dobutamine at 2 MCG/KG/MIN. 
Cont PO torsamide c. Rhyth - On tele - with AF. Goal to rate control , though underlying hypotention may be limiting. 
Will start Heparin for anticoagulation with goal 50-70 PTT. 
EP consulted re: rhythem control. 
Given past Amiodarone toxicity it is felt that antiarhythmic therapy will likely not be of benifit. 
Will anticoagulate and send out on coumadin. 
Will f/u with Dr. Fiermonte in coumadin clinic. 
2 ) Pulm - Will check CXR for pulm process as inciting cause. 
-&gt; negative 3 ) Renal - Baseline CRI. 
Will follow closely 4 ) ID - No issues 5 ) Rheum - H/O gout. 
Will cont allopurinol and Colchacine ( low dose ) 6 ) GI - H/O esophagitis. 
NO IR KCL. 
Cont pepcid and nexium. 
7 ) Immune - Cont Cellcept , prednisone and rapamycin. 
Will check rapa level give past high levels. 
Will start transplant eval while in house. 
8 ) Heme - Heparin for new Afib. 
Goal 50-70. 
Will start coumadin and get to goal INR of 2.0 prior to d/c.. 9 ) Endo - Will check TSH -&gt; returned normal. 
10 )Neuro/Psych - Cont clonapin 1 PRN 11 ) PPX - On heparin and PPI 12 ) FULL CODE Discharged to home with services on dobutamine as before and on coumadin for new PAF ADDITIONAL COMMENTS: Please take all of your medications as prescribed. 
If there is a discontinuation of you dobutamine for any reason please contact your cardiologist immediately. 
You have been started on coumadin for your atrial fibrilation. 
Blood draws to follow your INR will be necessary. 
If you notice weight gain , increased lower extremity swelling or increased SOB contact your cardiologist. 
If you have worsening palpitations , chest pain , dizziness or lightheadedness please seek medical attention. 
DISCHARGE CONDITION: Stable TO DO/PLAN: You will need blood draws starting 4/16/05 to measure your INR now that you are taking coumadin. 
It is essential that the VNA service call in the INR results to the PUO Anticoagulation Clinic at 132-202-5576. 
Alternatively it can be faxed to 545-904-2410. 
You will be contacted later in the same same day ( or following day if results obtained late ) with instructions for your coumadin dosing. 
No dictated summary ENTERED BY: FANIEL , GAYLENE G. , M.D. , PH.D. ( LG397 ) 11/29/05 @ 07 ****** END OF DISCHARGE ORDERS ******